ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.515
+0.155 (11.40%)
At close: Oct 27, 2026, 4:00 PM EDT
1.510
-0.005 (-0.33%)
After-hours: Oct 27, 2026, 4:06 PM EDT
ProKidney Revenue
ProKidney had revenue of $150.00K in the quarter ending June 30, 2026, a decrease of -32.13%. This brings the company's total for the last twelve months to $818.00K, up 55.22% year-over-year. In the year 2025, ProKidney had annual revenue of $893.00K with 1,075.00% growth. That makes ProKidney the 43,928th largest company in the world by revenue and 6,174th in the United States.
Revenue (ttm)
$818.00K
Revenue Growth
+55.22%
P/S Ratio
569.16
Revenue / Employee
$3,541
Employees
231
Market Cap
458.02M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 893.00K | 817.00K | 1,075.00% |
| Dec 31, 2024 | 76.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| REGENXBIO | 174.48M |
| Autolus Therapeutics | 117.39M |
| Assembly Biosciences | 74.85M |
| Prothena Corporation | 54.53M |
| Allogene Therapeutics | 4.64M |
| Ovid Therapeutics | 1.58M |
PROK News
- 5 hours ago - ProKidney Transcript: KOL event - Transcripts
- 5 hours ago - ProKidney Slides: KOL event - Filings
- 5 days ago - ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update - GlobeNewsWire
- 5 days ago - ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2026 - GlobeNewsWire
- 2 months ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 2 months ago - ProKidney reports Q2 EPS (15c), consensus (14c) - TheFly
- 2 months ago - ProKidney Quarterly report: Q2 2026 - Filings
- 2 months ago - ProKidney Earnings release: Q2 2026 - Filings